Roger Moore
Biotechnology
PILL
Australia
Biography
Roger Moore has 40 years experience in the international pharmaceutical industry, including almost 30 years as President of Novo Nordisk Japan. Mr Moore established Novo’s organisation in Japan as the first employee in 1977, and worked for the company until his retirement as Chairman at the end of 2007. From 2000, Roger Moore was appointed Senior Vice President, Japan and Oceania Region, responsible for Novo Nordisk’s business in Japan, Australia, New Zealand and the Pacific. He was also appointed a member of the Senior Management Board, Novo Nordisk A/S. In 2007 Mr Moore was awarded the Knight’s Cross of the Order of the Dannebrog by Queen Margrethe II of Denmark. Since 2008 he has split his time between Australia and Japan and has worked to assist selected Australian biotech companies and selected Japanese pharma companies in their international business development activities. Karen Logan – BCom, Grad Dip AppCorpGov, ACIS, AGIA, F Fin, GAICD Karen has extensive compliance, capital raising, merger and acquisition, IPO and backdoor listing experience in a diverse range of industries including technology, media, resources, health care and life science. She has assisted a substantial number of private start-up and established businesses transition to being publicly-listed companies for over 13 years. Karen is presently the principal of a consulting firm and secretary of a number of ASX-listed companies, providing corporate and accounting services to those clients.
Research Interest
Business deveploment